Retatrutide produces massive overall weight loss, but it reduces fat through a generalized caloric deficit
Clinicians should educate individuals about the potential interactions between these substances and GLP-1s and routinely screen for substance use using validated short tools such as those proposed by the Institute of Medicine for Social and Behavioral Determinants of Health [188]
It competes with sulfate-reducing bacteria for resources, effectively crowding them out over time
Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D, et al
Depending on the exact brand name drug, GLP-1s are FDA-approved to help manage type 2 diabetes, to facilitate weight management, or to help with both
Since some studies show that GLP-1 drugs may have an impact on addictive behaviors, this makes scientists wonder what other neurological impacts the drug can have